Improvement of adjunctive berberine treatment on negative symptoms in patients with schizophrenia
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improvement of adjunctive berberine treatment on negative symptoms in patients with schizophrenia
Authors
Keywords
-
Journal
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-17
DOI
10.1007/s00406-021-01359-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peripheral immune markers and antipsychotic non-response in psychosis
- (2021) Daniela Enache et al. SCHIZOPHRENIA RESEARCH
- Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits
- (2020) David R. Goldsmith et al. Frontiers in Psychiatry
- Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study
- (2020) Ying-Xuan Chen et al. Lancet Gastroenterology & Hepatology
- Berberine ameliorates rats model of combined Alzheimer’s disease and type 2 diabetes mellitus via the suppression of endoplasmic reticulum stress
- (2020) Wei-ting Xuan et al. 3 Biotech
- Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
- (2019) Robert A. McCutcheon et al. TRENDS IN NEUROSCIENCES
- Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
- (2019) Maximilian Huhn et al. LANCET
- Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
- (2019) Stephen J. Kaar et al. NEUROPHARMACOLOGY
- Ameliorating effects of berberine on MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia
- (2019) Samaneh Ghotbi Ravandi et al. NEUROSCIENCE LETTERS
- Effect of Berberine on C-reactive protein: A systematic review and meta-analysis of randomized controlled trials
- (2019) Mohammad Beba et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Berberine mitigates cognitive decline in an Alzheimer’s Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance
- (2019) Ying Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review
- (2018) Laura Orsolini et al. Current Neuropharmacology
- Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: Association with pro-inflammatory cytokine levels
- (2018) Lulu Zhang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Relation of inflammatory markers with symptoms of psychotic disorders: a large cohort study
- (2018) E.J. Liemburg et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Altered Serum Tumor Necrosis Factor and Interleukin-1β in First-Episode Drug-Naive and Chronic Schizophrenia
- (2018) Furong Zhu et al. Frontiers in Neuroscience
- TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia
- (2018) David R. Goldsmith et al. SCHIZOPHRENIA RESEARCH
- Changes in plasma levels of nitric oxide metabolites and negative symptoms after 16-week minocycline treatment in patients with schizophrenia
- (2018) Fang Liu et al. SCHIZOPHRENIA RESEARCH
- Effects of berberine on a rat model of chronic stress and depression via gastrointestinal tract pathology and gastrointestinal flora profile assays
- (2017) Xiaohui Zhu et al. Molecular Medicine Reports
- Berberine alleviates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress
- (2017) Li-Chao Zhang et al. Experimental and Therapeutic Medicine
- Berberine alleviates postoperative cognitive dysfunction by suppressing neuroinflammation in aged mice
- (2016) Zhijie Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease
- (2016) Xinxia Chang et al. Journal of Translational Medicine
- Berberine up-regulates the BDNF expression in hippocampus and attenuates corticosterone-induced depressive-like behavior in mice
- (2016) Ji-duo Shen et al. NEUROSCIENCE LETTERS
- Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1.
- (2016) Stefan Leucht et al. SCHIZOPHRENIA BULLETIN
- Current knowledge and pharmacological profile of berberine: An update
- (2015) Anil Kumar et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension
- (2015) Jiarong Lan et al. JOURNAL OF ETHNOPHARMACOLOGY
- C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications
- (2015) B S Fernandes et al. MOLECULAR PSYCHIATRY
- The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China
- (2015) Chuan Shi et al. SCHIZOPHRENIA RESEARCH
- Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups
- (2015) Jamie Joseph et al. SCHIZOPHRENIA RESEARCH
- Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: A double blind, randomized, controlled trial
- (2014) Fang Liu et al. SCHIZOPHRENIA RESEARCH
- Increased serum interleukin-6 levels in early stages of psychosis: Associations with at-risk mental states and the severity of psychotic symptoms
- (2013) Alexander Stojanovic et al. PSYCHONEUROENDOCRINOLOGY
- Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention
- (2012) Shu Meng et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
- (2012) Imran B Chaudhry et al. JOURNAL OF PSYCHOPHARMACOLOGY
- In Vivo Measurements of Glutamate, GABA, and NAAG in Schizophrenia
- (2012) Laura M. Rowland et al. SCHIZOPHRENIA BULLETIN
- Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond
- (2011) Urs Meyer et al. PHARMACOLOGY & THERAPEUTICS
- C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia
- (2011) Mounir H. Fawzi et al. PSYCHIATRY RESEARCH
- A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia
- (2009) Yechiel Levkovitz et al. JOURNAL OF CLINICAL PSYCHIATRY
- Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders
- (2009) S. K. Kulkarni et al. PHYTOTHERAPY RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started